NCT06116799

Managing Pain in Patients With Plantar Fasciitis - A Blinded Randomized Controlled Trial

Terminated NA Last updated 3 November 2023

What this trial tests

NA trial testing Orthotic in Plantar Fasciitis in 45 participants. Terminated before completion.

Timeline

1 April 2022

Primary endpoint
6 May 2023

6 May 2023

Quick facts

Lead sponsor	Massachusetts General Hospital
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	45
Start date	1 April 2022
Primary completion	6 May 2023
Estimated completion	6 May 2023
Sites	1 location across United States

Drugs / interventions tested

• Orthotic

Conditions studied

• Plantar Fasciitis — all drugs for Plantar Fasciitis →

Sponsor

Massachusetts General Hospital

Who can join

18 and older, any sex, with Plantar Fasciitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Plantar fasciitis (PF), a leading cause of persistent heel pain, results in almost a million physician visits annually. Conservative treatment is often the first line of management with insoles being frequently prescribed. While multiple studies have compared insoles based on the degree of customization to foot contour, the literature is lacking in data comparing insoles based on their material. In this randomized clinical trial, we compared the early effects of polyethylene (PE), polyurethane (PU), and carbon fiber insoles in the treatment of PF, using a set of patient-reported outcomes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.